prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - F. Pathologic Interpretation: A. SPECIMEN LABELED SENTINEL NODE # 1 COUNT. LEFT BREAST: One lymph node, negative for carcinoma (0/1). B. SPECIMEN LABELED SENTINEL NODE # 2 COUNT. LEFT BREAST: METASTATIC DUCTAL CARCINOMA in one lymph node (1/1), measuring 0.5 cm in linear dimension. C. SPECIMEN LABELED SENTINEL NODE #3 COUNT. ) LEFT BREAST: One lymph node, negative for carcinoma (0/1). D. SPECIMEN LABELED "NON-SENTINEL LYMPH NODE LEFT BREAST": One lymph node, negative for carcinoma (0/1). E. LEFT BREAST EXCISION: INVASIVE DUCTAL CARCINOMA, moderately differentiated, Nottingham grade 2 (3+2+1=6), 8.5 cm in. greatest dimension, asociated with calcifications. Nerarest margins: Posterior, 1 mm (E2); medial, 3mm (E16); anterior, 5 mm (E4); lateral, inferior and. superior, >5mm. Negative for lymphovascular invasion. DUCTAL CARCINOMA IN SITU, intermediate nuclear grade, solid and cribriform type, DIN II, associated. with necrosis and calcifications, present is 8 out of 17 slides. Nearest margins: inferior <1mm (E7); medial 1mm (E12); posterior 2mm (E2): ;anterior 5mm, superior and. lateral >5mm. Extensive intraductal component negative. Note: Immunohistochemistry stains on a prior specimen were: ER. NEGATIVE (<1%). PR. NEGATIVE (<1%). HER2. NEGATIVE (0). F. SPECIMEN LABELED "ADDITIONAL ANTERIOR MARGIN, LEFT BREAST": Negative for carcinoma. Skin with no specific pathologic changes. G. LEFT LYMPH NODE DISSECTION, AXILLA: Two lymph nodes, negatve for carcinoma (0/2). H. LEFT LYMPH NODE DISSECTION, AXILLA: Nineteen lymph nodes, negative for carcinoma (0/19). Pathology Cancer Case Summary: INVASIVE CARCINOMA OF THE LEFT BREAST: Specimen Type: Partial breast. Procedure: Excision with wire-guided localization. Lymph Node Sampling: Sentinel lymph node(s). Axillary dissection (partial or complete dissection). Other lymph nodes (eg, location not identified). Specimen Integrity: Multiple designated specimens (eg, main excision and identified margins). Specimen Size: Greatest dimension: 9.0 cm. Additional dimensions: 6.5 x 3.8 cm. Specimen Laterality: Left. Tumor Size: Size of Largest Invasive Carcinoma: Greatest dimension of largest focus of invasion over 0.1. cm: 8.5 cm. Additional dimensions: 6.0 x 3.3 cm. Tumor Focality: Single focus of invasive carcinoma. Macroscopic and Microscopic Extent of Tumor: Skin: Skin is not present. Nipple: DCIS does not involve the nipple epidermis. Skeletal Muscle: No skeletal muscle present. Ductal Carcinoma in Situ: DCIS is present. Extensive intraductal component (EIC) negative. Size (Extent) of DCIS: Number of blocks with DCIS: 8. Number of blocks examined: 17. Architectural Patterns: Cribriform. Solid. Nuclear Grade: Grade II (intermediate). Necrosis: Present, central (expansive "comedo" necrosis). Lobular Carcinoma in Situ: Not identified. Histologic Type of Invasive Carcinoma: Invasive ductal carcinoma (no special type or not otherwise. specified). Histologic Grade: Glandular (Acinar)/Tubular Differentiation: Score 3. Nuclear Pleomorphism: Score 2. Mitotic Count: Score 1. Overall Grade: Grade 2. Margins: Uninvolved by invasive carcinoma. Distance from closest margin: 1 mm, posterior, medial. Specify margins: Distance from superior margin: >5 mm. Distance from inferior margin: > 5mm (E7). Distance from anterior margin: 5 mm (E4). Distance from posterior margin: 1 mm (E2). Distance from medial margin: 3 mm (E16). Distance from lateral margin: >5 mm. Uninvolved by DCIS. Distance from closest margin: <1 mm, inferior. Specify margins: Distance from superior margin: >5 mm. Distance from inferior margin: <1mm (E7). Distance from anterior margin: 5 mm (E4). Distance from posterior margin: 2 mm (E2). Distance from medial margin: 1 mm (E12). Distance from lateral margin: >5 mm. Treatment Effect: Response to Presurgical Therapy: In the breast: No known presurgical therapy. Lymph-Vascular Invasion: Not identified. Dermal Lymph-Vascular Invasion: Not identified. Lymph Nodes: Number of sentinel lymph nodes examined: 3. Total number of lymph nodes examined (sentinel and nonsentinel): 25. Number of lymph nodes with macrometastases: 1. Number of lymph nodes with micrometastases: 0. Number of lymph nodes with isolated tumor cells: 0. Size of largest metastatic deposit: 5.0 mm. Extranodal Extension: Not identified. Method of Evaluation of Sentinel Lymph Nodes: Hematoxylin and cosin (H&E), one level. Primary Tumor: pT3: Tumor >50 mm in greatest dimension. Regional Lymph Nodes: pN1a: Metastases in 1 to 3 axillary lymph nodes, at least 1 metastasis greater than 2.0 mm. Distant Metastasis: Not applicable. Ancillary Studies: Estrogen Receptor: Performed on another specimen. Specify specimen: Results: NEGATIVE, Less than 1% immunoreactive cells present. Progesterone Receptor: Performed on other specimen. Specify specimen: Results: NEGATIVE, Less than 1% immunoreactive cells present. Her2: Performed on another specimen. Specify specimen: Results: NEGATIVE, Score 0. Microcalcifications: Present in DCIS. Present in invasive carcinoma. NOTE: Some immunohistochemical antibodies are analyte specific reagents (ASRs) validated by our laboratory. These ASRs are clinically useful indicators that do not require FDA approval. There clance are used: ID5 =ER, PgR 636=PR, A485=HER2, H-11=EGFR. All immunohistochemical stains are used with formalin or molecular fixed. paraffin embedded tissue. Detection is by. The results are read by a pathologist as positive or negative. As the attending pathologist, I attest that I: (i) Examined the. relevant preparation(s) for the specimen(s); and (ii) Rendered the. diagnosis(es). Intraoperative Consultation. A. Sentinel node # 1 Count. Left breast: Negative for carcinoma (0/1). B. Sentinel node # 2 count. left breast: One lymph node, positive for carcinoma (1/1). C. Sentinel node # 3 count. left breast: Negative for carcinoma (0/1). Clinical History: Breast cancer. Operation Performed. Left partial mastectomy and left sentinel lymph node biopsy. Specimen(s) Received: A: SENTINEL NODE # 1 COUNT i. LEFT BREAST. B: SENTINEL NODE # 2 COUNT. i LEFT BREAST. C: SENTINEL NODE #3 COUNT. i) LEFT BREAST. D: NON-SENTINEL LYMPH NODE LEFT BREAST. E: LEFT BREAST MASS-ONE STITCH SHORT SUPERIOR, LONG IS LATERAL. F: ADDITIONAL ANTERIOR MARGIN. G: LEFT AXILLA. H: LEFT AXILLARY CONTENTS. Gross Description: A. Received fresh labeled "Sentinel node # 1 Count. - left breast". The specimen consists of a lymph. node with surrounding fibroadipose tissue which measures 1.5 x 1.5 x 0.2 cm. The specimen is submitted in. toto in cassette. B. Received fresh labeled "Sentinel node # 2 count. left breast". The specimen consists of a lymph node. with. surrouding fibroadipose tissue which measures 1.5 x 1.0 x 0.2 cm. The specimen is submitted in toto in. cassette !. C. Received fresh labeled "Sentinel node # 3 count. left breast". The specimen consists of a lymph node. with. surrounding fibroadipose tissue which measures 1.5 x 1.2 x 0.2 cm. The specimen is submitted in toto in. cassette (. D. Received in formalin labeled "Non-sentinel lymph node - left breast". The specimen consists of a lymph. node with. surrounding fibroadipose tissue which measures 1.0 x 1.0 x 0.5 cm. The specimen is bisected and. submitted in toto in. one cassette. E. Received fresh labeled "Left breast mass - one stitch short superior - long lateral". The specimen consists. of a left lumpectomy specimen which measures 9.0 cm from medial to lateral by 6.5 cm from inferior to. superior by 3.8 cm from anterior to posterior. There are two sutures; the long designating lateral and the. short is designating superior. There is a firm, white, irregularly shaped and poorly defined mass located in. the center of the specimen with diffuse extension to the medial and lateral margin. The extensions are. surrounding by white indurated areas. The tumor appears to be less than 1mm from the superior margin. less than 1mm from the posterior margin. The tumor with indurated area appears to be less than 1mm from. the inferior margin. The tumor appears to be less than 1mm from the anterior margin, less than 1mm from. the medial margin and less than 1mm from the lateral margin. The main part of the tumor measures 3.5. x 3.5 x 3.0 cm. But with the extensions and indurated areas the tumor measures 9.0 x 6.5 x 3.8 cm. The. specimen isinked as follows: Posterior black. Anterior yellow. Superior blue. Inferior green. Lateral orange. Medial red. A section of tumor was taken fresh from frozen section for research. Approximately 50% of the section is. submitted. Sections are submitted as follows: Cassettes #1&2. Tumor in relation to deep posterior margin. Cassettes #3&4. Representative sections of tumor in relation to anterior margin. Cassettes #5&6. Representative section of tumor in relation to superior margin. Cassettes #7&8. Relationship of tumor to inferior margin. Cassettes #9&10. Relationship of tumor to the lateral margin. Cassettes #11&12. Representative section of tumor to the medial margin. Cassette #13. Additional section of tumor near the posterior margin. Cassette #14. Additional section of tumor near anterior margin. Cassette #15. Representative section of possible biopsy cavity. Cassette #16. Representative section of tumor with central focal hemorrhage. Cassette #17. Possible biopsy site. F. Received in formalin labeled "Additional anterior margin". The specimen consists of a fragment of skin with. attached. fibroadipose tissue, skin measures 12.0 x 1.1 cm and is tan-brown in color. Adipose tissue. measures 1.5 x 0.8 cm. No. lesions are identified. The specimen is sectioned and skin is submitted toto in. five cassettes. G. Received in formalin labeled "Left axilla". The specimen consists of a fragment of fibroadipose tissue which. measures. 2.0 x 1.5 x 0.9 cm. The largest lymph node measures 1.0 x 0.5 x 0.5 cm and is inked green. There. is one additional lymph node identified. The specimen is submittedin toto in cassette one. The largest lymph node. is bisected. H. Received in formalin labeled "Left axillary contents". The specimen consists of a fibroadipose tissue which. measures. 11.0 x 8.0 x 4.0 cm. The specimen is unoriented. No skeletal muscle is identified. The largest. lymph node measures. 2.6 x 1.5 x 0.7 cm. The sections are submitted as follows: Cassette #1. Three lymph nodes. Cassette #2. One lymph node. Cassette #3. One lymph node. Cassette #4. One lymph node. Cassette #5. One possible lymph node. Cassette #6. Two lymph nodes. Cassette #7. Four possible lymph nodes. Cassette #8. Three possible lymph nodes. Cassette #9. Three possible lymph nodes. Cassette #10. Four possible lymph nodes.

expanded version (tokens=3201) : 
 Histological Classification:
- Specimen labeled Sentinel Node #2: Metastatic Ductal Carcinoma
- Left Breast Excision: Invasive Ductal Carcinoma (moderately differentiated)
- Ductal Carcinoma in Situ (solid and cribriform type, intermediate nuclear grade)

Necrosis:
- Ductal Carcinoma in Situ associated with necrosis and calcifications (present in 8 out of 17 slides)

Tumor Infiltrating Lymphocytes:
- Not mentioned in the report

Histological Grade:
- Left Breast Excision: Nottingham grade 2 (3+2+1=6)

Nuclear Grade:
- Ductal Carcinoma in Situ: Intermediate nuclear grade (Grade II)

Lymphovascular Invasion:
- Negative for lymphovascular invasion

Calcification:
- Present in Ductal Carcinoma in Situ and invasive carcinoma

Receptor Status (IHC):
- ER (Estrogen Receptor): Negative (<1% immunoreactive cells present)
- PR (Progesterone Receptor): Negative (<1% immunoreactive cells present)
- HER2: Negative (Score 0)

Ancillary Testing Results:
- No other ancillary testing results mentioned in the report

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=3360) : 
 Histological classification: Metastatic Ductal Carcinoma in the sentinel lymph node. Invasive Ductal Carcinoma (moderately differentiated) with associated necrosis and calcifications in the left breast excision. Ductal Carcinoma in Situ (solid and cribriform type, intermediate nuclear grade). Histological grade: Nottingham grade 2 (3+2+1=6). ER and PR negative (<1% immunoreactive cells present). HER2 negative (Score 0). No lymphovascular invasion identified.

